Chemistry:FLS-359

From HandWiki

FLS-359 is a drug which acts as a selective allosteric inhibitor of the enzyme sirtuin 2 (SIRT2). It has moderate potency, inhibiting SIRT2 with an IC50 of 3 μM, and shows broad-spectrum antiviral effects against both RNA and DNA viruses including hepatitis B and cytomegalovirus.[1][2][3]

References

  1. "An allosteric inhibitor of sirtuin 2 deacetylase activity exhibits broad-spectrum antiviral activity". The Journal of Clinical Investigation 133 (12). June 2023. doi:10.1172/JCI158978. PMID 37317966. 
  2. "An allosteric inhibitor of sirtuin 2 blocks hepatitis B virus covalently closed circular DNA establishment and its transcriptional activity". Antiviral Research 226. June 2024. doi:10.1016/j.antiviral.2024.105888. PMID 38641024. 
  3. "Generation of a panel of mutants that are resistant to standard of care therapies in a clinically relevant strain of human cytomegalovirus for drug resistance profiling". Antiviral Research 241. September 2025. doi:10.1016/j.antiviral.2025.106237. PMID 40653174.